Latest news with #SatishMehta
&w=3840&q=100)
Business Standard
17-07-2025
- Business
- Business Standard
Emcure Pharma, Sanofi India shares edge higher; what's behind the move?
Emcure Pharmaceuticals share price today: Shares of pharma major Emcure Pharmaceuticals rose over 2 per cent to hit an intraday high of ₹1,394.8 on the National Stock Exchange (NSE) after the company announced a distribution and promotion partnership with Sanofi India on Wednesday. At 9:30 AM, the stock was quoting at ₹1,382.5, up 1.5 per cent from the previous day's close of ₹1,362.5. In comparison, the benchmark NSE Nifty50 index was trading marginally down by 15.5 points at 25,196.55 levels. The total market capitalisation of Emcure Pharmaceuticals stood at ₹26,216.58 crore. Shares of Sanofi India also gained around 1.5 per cent to hit an intraday high of ₹5,975. At the time of writing, the stock was quoting 1.2 per cent higher at ₹5,956.5. Emcure Pharmaceuticals and Sanofi India have entered a distribution and promotion partnership aimed at expanding access to Sanofi's oral anti-diabetic (OAD) products across India. Effective immediately, Emcume will exclusively distribute and promote Sanofi's OAD range of products, including established brands like Amaryl and Cetapin. However, Sanofi India will continue to own and manufacture these brands across Sanofi's plants in India and internationally. "Emcure will leverage its strengths to engage healthcare professionals and expand the reach of these therapeutic solutions for patients who need them across all of India," the company said in an exchange filing. "With our strong distribution network in India, Sanofi's trusted oral anti-diabetic medicines will be available to more patients who need them. This collaboration complements our existing diabetes portfolio, creating a comprehensive offering for the millions living with diabetes and supporting better diabetes care across the country,' said Satish Mehta, chief executive officer and managing director at Emcure Pharmaceuticals. About Emcure Pharma Headquartered in Pune, Emcure Pharmaceuticals is engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products. Emcure develops and manufactures a wide range of differentiated pharmaceutical products designed to improve patient health and well-being across several major therapeutic areas. Established in 1981, Emcure is ranked as the 12th largest pharma company in India in terms of domestic sales for MAT June 2024. The company has a presence in more than 70 countries globally, including Europe and Canada.
Time of India
16-07-2025
- Business
- Time of India
Emcure, Sanofi ink distribution pact for oral anti-diabetic products in India
Emcure Pharmaceuticals Ltd and Sanofi India Ltd on Wednesday said they have entered into an exclusive distribution and promotion agreement for the latter's oral anti-diabetic products in India with immediate effect. Under the agreement, Emcure will exclusively distribute and promote Sanofi India's OAD (oral anti-diabetic) range of products that include brands like Amaryl and Cetapin, the two companies said in a joint statement. Explore courses from Top Institutes in Select a Course Category Operations Management Data Analytics Finance Data Science Artificial Intelligence MBA Product Management PGDM Technology Project Management Healthcare Cybersecurity Public Policy Degree MCA Leadership Management CXO Others Digital Marketing healthcare others Design Thinking Data Science Skills you'll gain: Quality Management & Lean Six Sigma Analytical Tools Supply Chain Management & Strategies Service Operations Management Duration: 10 Months IIM Lucknow IIML Executive Programme in Strategic Operations Management & Supply Chain Analytics Starts on Jan 27, 2024 Get Details Sanofi India will continue to own and manufacture these brands across its plants in India and internationally, it added. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Hörspezialisten verlieren Kunden: Dieses 89€-Gerät spricht sich herum Top Trending News Today Mehr erfahren Undo "With our strong distribution network in India, Sanofi's trusted oral anti-diabetic medicines will be available to more patients who need them," Emcure Pharmaceuticals CEO and MD Satish Mehta said. Further, he said, "This collaboration complements our existing diabetes portfolio, creating a comprehensive offering for the millions living with diabetes and supporting better diabetes care across the country." Live Events Similarly, Sanofi General Manager Pharma Southeast Asia and India & MCO Lead, Eric Mansion, said, "With Emcure's wide and deeply penetrated presence across India, we are confident of tapping into the full growth potential of our best-in-class and industry-leading OADs Amaryl and Cetapin. This partnership will truly benefit both - the patients who need them and the healthcare professionals who trust and prescribe them." The two companies said there would be no people transition from Sanofi India to Emcure under their distribution and promotion agreement.
Time of India
14-07-2025
- Business
- Time of India
Want to boost your credit score? Follow these 5 steps to get home loans at lower interest rates
A credit score can be the deciding factor between financial ease and costly borrowing. From securing a home loan to getting approved for a high-limit credit card, your score influences not only the chances of approval but also the interest rates you'll pay. Hitting a credit score of 800 is like having a golden key to the best loan and credit card deals. It opens the door to low-interest financing, helping you save big! While a score above 800 is seen as excellent and 670–739 is considered good, anything under 600 can raise red flags for lenders and significantly limit your financial options. If your score is on the lower side, don't worry! Financial experts suggest five practical ways to steadily improve your credit profile and secure better financial opportunities: 1. Pay on time, in full: Your payment history is the single most important factor in calculating your credit score. Missing even one payment or paying only the minimum due can leave a negative mark, especially if you already have a limited or shaky credit history. "Many underestimate the impact of missing even one EMI. It creates a negative mark in the scoring algorithm, signalling unreliability to lenders," Satish Mehta, Founder of Athena CredXpert told ET. Experts recommend automating EMIs and credit card payments to avoid delays. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Cách giao dịch ETH/USD mà không cần nắm giữ Ether IC Markets Tìm hiểu thêm Undo Even though paying the minimum due may not hurt your score immediately, the high interest (up to 40%) still impacts your finances. 2. Use secured loans to rebuild credit: If traditional loans are out of reach due to a bad score, secured loans backed by fixed deposits or gold can help. These are easier to obtain and are reported to credit bureaus. Using them for small, planned expenses and repaying on time can help you rebuild your profile. "Start small and focus on consistent, timely repayments to restore trust," advises Raj Khosla, Founder & MD, MyMoneyMantra told the outlet. Regular repayments over six to nine months can outweigh earlier defaults. 3. Keep credit utilisation in check: Your credit utilisation ratio—the percentage of your credit limit used—also affects your score. Using more than 30-40% of your credit limit regularly can be seen as risky behaviour, even if you pay your dues on time. Spread your spending across multiple cards rather than maxing out one. However, avoid applying for too many new cards in a short time, as this can raise red flags with credit bureaus. 4. Avoid frequent EMI conversions: While turning a large credit card bill into EMIs may seem convenient, doing it frequently can damage your score. Raj Khosla told ET that, "Each EMI conversion shows up as an inability to pay the balance outright, which can lower your score." If you must borrow, opt for a personal loan, it usually has a lower interest rate and fixed repayment terms. While it can still affect your credit score, it's a better option than high-interest credit card debt. 5. Handle overdue loans carefully: If you have overdue payments, avoid taking new loans to repay old ones. This often leads to a debt trap. "Swapping one debt for another doesn't solve the problem; it just delays it," Satish Mehta said. Focus on clearing smaller high-interest loans first, and seek help from a credit counsellor to structure repayments if needed. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now
The Print
08-06-2025
- Business
- The Print
Jaipur Foot maker BMVSS invited to UN to showcase work on disability welfare
The statement said that the organisation holds a special consultative status with the Economic and Social Council of the United Nations. 'Seven years ago the United Nations organized a special meeting of permanent representatives of various member countries to showcase the Jaipur Foot,' it said. According to the statement, BMVSS Founder and Chief Patron D R Mehta and Chairman Satish Mehta will make presentations in two sessions on Tuesday, which will be attended by permanent representatives of various countries and other dignitaries. Jaipur, Jun 8 (PTI) Shri Bhagwan Mahavir Viklang Sahayata Samiti (BMVSS), known globally for its 'Jaipur Foot' and rehabilitation for persons with disabilities has been invited to the United Nations headquarters in New York to present its initiatives for disability welfare, a statement issued here said. The organisation has held 114 special camps in various countries in recent years in collaboration with the Ministry of External Affairs (MEA) and rehabilitated more than 50,000 disabled persons from 44 countries. The United Nations has specially invited BMVSS to discuss various issues related to the disabled (Divyangs) as it has worked extensively in India and abroad, the statement added. Last year, former President of the United Nations General Assembly Dennis Francis had specially visited the BMVSS centre to know the manufacturing process of Jaipur Foot. PTI AG OZ OZ This report is auto-generated from PTI news service. ThePrint holds no responsibility for its content.
News18
08-06-2025
- Health
- News18
Jaipur Foot maker BMVSS invited to UN to showcase work on disability welfare
Jaipur, Jun 8 (PTI) Shri Bhagwan Mahavir Viklang Sahayata Samiti (BMVSS), known globally for its 'Jaipur Foot' and rehabilitation for persons with disabilities has been invited to the United Nations headquarters in New York to present its initiatives for disability welfare, a statement issued here said. According to the statement, BMVSS Founder and Chief Patron D R Mehta and Chairman Satish Mehta will make presentations in two sessions on Tuesday, which will be attended by permanent representatives of various countries and other dignitaries. The statement said that the organisation holds a special consultative status with the Economic and Social Council of the United Nations. 'Seven years ago the United Nations organized a special meeting of permanent representatives of various member countries to showcase the Jaipur Foot," it said. The organisation has held 114 special camps in various countries in recent years in collaboration with the Ministry of External Affairs (MEA) and rehabilitated more than 50,000 disabled persons from 44 countries. The United Nations has specially invited BMVSS to discuss various issues related to the disabled (Divyangs) as it has worked extensively in India and abroad, the statement added. Last year, former President of the United Nations General Assembly Dennis Francis had specially visited the BMVSS centre to know the manufacturing process of Jaipur Foot. PTI AG OZ OZ
